International Association of Campus Law Enforcement Administrators Launches National Campus Drone Readiness Program, Selecting Draganfly to Provide Drone Systems, Services and Training in Alignment with Emerging U.S. Drone Policy

Orlando, FL, June 25, 2026 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8) (“Draganfly” or the “Company”), an award-winning Unmanned Systems Developer and capabilities integrator, today announced with the International Association of Campus Law Enforcement Administrators (IACLEA) the launch of the IACLEA national Campus Drone Implementation & Readiness Program for colleges and universities across the United States.

Seegnal to Deploy its Medication Safety Platform Across Nazareth Hospital EMMS, Expanding its Israeli Hospital Footprint

Historic regional trauma center and teaching hospital adopts Seegnal’s patient-specific clinical decision support, expanding the Company’s footprint across Israel’s healthcare system

Historic regional trauma center and teaching hospital adopts Seegnal’s patient-specific clinical decision support, expanding the Company’s footprint across Israel’s healthcare system

Cell-based Assays Market Worth USD 46.87 Billion by 2035 | SNS Insider

The U.S. Cell-based Assays Market is projected to grow from USD 3.44 Billion in 2025 to USD 7.31 Billion by 2035, while Europe is expected to expand from USD 5.62 Billion to USD 12.49 Billion, supported by increasing drug discovery activities, biologics research, and adoption of advanced cell-based testing platforms.

The U.S. Cell-based Assays Market is projected to grow from USD 3.44 Billion in 2025 to USD 7.31 Billion by 2035, while Europe is expected to expand from USD 5.62 Billion to USD 12.49 Billion, supported by increasing drug discovery activities, biologics research, and adoption of advanced cell-based testing platforms.

Axonex and YAS Collaborate with a Global Insurance Group to Develop Embedded Insurance for Robots Innovative InsurTech Solution Drives AI and Robotics Adoption Across Hong Kong and Southeast Asia

Hong Kong, June 25, 2026 (GLOBE NEWSWIRE) — Mint Incorporation Limited (“Mint” or the “Company”, together with its subsidiaries, the “Group”, NASDAQ: MIMI), a Hong Kong-based company strategically focused on artificial intelligence (AI) and robotics, and an established business interior design and fit-out works provider, today announced that its wholly-owned subsidiary, Axonex Intelligence Limited (“Axonex”), has entered into a collaboration with YAS, Hong Kong’s leading embedded insurance technology company, with underwriting provided by an insurance company under a global insurance group headquartered in Switzerland, to jointly develop an embedded micro-insurance solutions purpose-built for commercial robots, among the first of its kind in Asia. Through this innovative insurance solution, the initiative helps remove a significant barrier to enterprise adoption of AI-powered robots, accelerating the commercial deployment of robotics across Hong Kong and Southeast Asia.

BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform

MELVILLE, N.Y., June 25, 2026 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative,” “BRTX,” or the “Company”) (Nasdaq:BRTX), a late-stage clinical regenerative medicine company focused on stem cell-based therapies and products, today announced the successful completion of manufacturing for its BRTX-100 Phase 2 clinical trial, marking a key milestone in the development of its lead cell therapy candidate and underscoring the strength of the Company’s vertically integrated regenerative medicine platform.

Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies

Denver, CO and London, UK – 25 June 2026: Excellere Partners (“Excellere”), a Denver-based private equity firm specializing in partnering with entrepreneurs and management teams, and GHO Capital Partners LLP (“GHO”), a specialist investor in global healthcare, today announced the completion of the sale of Biocare Medical (“Biocare”), a global leader in immunohistochemistry (IHC), in situ hybridization (ISH) and fluorescence in situ hybridization (FISH) solutions, to Agilent Technologies, Inc. (“Agilent”, NYSE:A).

Provectus Biopharmaceuticals Launches Veripure™, an Open Science Program for Medical Research Access to PV-10 (rose bengal sodium)

KNOXVILLE, Tenn., June 25, 2026 (GLOBE NEWSWIRE) — Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT), a clinical-stage biotechnology company developing pharmaceutical grade rose bengal sodium (“RBS”) active pharmaceutical ingredient (“API”) as a platform therapeutic, today announced the launch of its Veripure open science research program. Veripure makes PV-10, formulated from pharmaceutical-grade RBS API, freely available to qualified researchers globally without restrictive constraints on study direction, design, or findings. Researchers interested in studying RBS for therapeutic applications through the Veripure program are invited to contact Provectus directly at veripure@pvct.com.

SPIRIT BLOCKCHAIN CAPITAL COMPLETES SHARES FOR SERVICES ISSUANCE

Vancouver, BC, June 25, 2026 (GLOBE NEWSWIRE) — Spirit Blockchain Capital Inc. (CSE: SPIR) (“Spirit” or the “Company”), a Canadian-based publicly listed company focused on blockchain infrastructure and digital asset opportunities, is pleased to announce that it has completed its previously announced shares for services issuance, originally announced on June 18, 2026.

NuCube Energy to Become a Publicly Listed Company Through Business Combination with Launch Two Acquisition Corp.

Idaho Falls, Idaho & Oakland, California, June 25, 2026 (GLOBE NEWSWIRE) — NuCube Energy, Inc. (“NuCube”), an advanced-nuclear technology company productizing factory-built microreactors, and Launch Two Acquisition Corp. (NASDAQ: LPBB) a special purpose acquisition company, (“Launch Two” collectively, the “Parties”), today announced that they have entered into a definitive business combination agreement (the “Transaction” or the “Business Combination”) that would result in NuCube becoming a publicly listed company. Upon closing, the combined company is expected to be listed on Nasdaq or NYSE.

Digital Currency X Technology Enters Into Securities Purchase Agreement for a Private Placement of US$700 Million of Units, Payable in U.S. Dollars or Digital Assets, to Advance Its Digital Asset Treasury Strategy

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) — Digital Currency X Technology Inc. (Nasdaq: DCX) (“DCX” or the “Company”), a digital asset treasury management company, today announced that it has entered into a securities purchase agreement (the “Agreement”) with certain investors for a private placement of an aggregate of US$700,000,000 of units of the Company (the “Units”). Each Unit consists of one Class A ordinary share, par value US$0.0001 per share (the “Ordinary Share”), and three warrants (the “Warrants”). The purchase price per Unit is US$2.11, and the Warrants have an exercise price of US$2.11 per share (subject to adjustment as set forth in the Warrants), are exercisable on or after June 24, 2026, and will expire three years after such date. The Company intends to use the proceeds from the private placement for working capital and general corporate purposes, including the continued execution of its digital asset treasury strategy and the expansion of its newly established AI cloud computing services business, further diversifying the Company’s revenue base.